IAH

IAH is part of the Biotechnology and Biological Sciences Research Council (BBSRC) and has two sites at Compton and Pirbright. It's mission is to understand the process of infectious diseases and from that knowledge improve the efficacy and sustainability of livestock farming, enhance animal welfare, safeguard the supply and safety of food and protect the environment. The Pirbright Laboratory works exclusively on exotic viral diseases of livestock for which it carries out basic and applied research and provides national and international reference laboratory services.  IAH-Pirbright provides the FAO/OIE World Reference Laboratory for FMD (WRL-FMD).

Dr. David J. Paton

MA, VetMB, PhD, MRCVS
CA and FMD subgroup coordinator.
Head of WRL-FMD and previously head of the OIE CSF Reference Laboratory at VLA-Weybridge. Previous participant in EU concerted actions on PRRS and FMD, and in EU RTD projects on CSF (as coordinator) and equine arteritis virus. Partner in newly approved EU RTD project on FMD. Member of several working groups concerning FMD and other list A diseases. Secretary of European Society for Veterinary Virology (1994-2000). Editorial Board member of the scientific journals Veterinary Research and Journal of Comparative Pathology.

Dr. John B. Bashiruddin

BSc, PhD
Project Manger and Leader of WP on Central Network Resource.
Previously Head of Molecular Biology in Teramo Italy, coordinator of an FP5 project, participant in COST project, Senior Scientist at VLA, UK, and member of FAO working group on other reportable diseases (CBPP). He provides the day-to-day coordination of the FMD activities and has a leading role in many of the FMD workpackages.

Dr. Paul V. Barnett

CBiol, MIBiol, PhD
Leader of WP on FMD vaccine reserves.
Head of the FMD Vaccines Group at IAH, Pirbright. Began his career in 1976 with the Wellcome Foundation Ltd, Foot-and-Mouth Disease Vaccine Laboratory before moving to the International FMD Vaccine Bank, at IAH, Pirbright in 1991. Awarded the degree of Doctor of Philosophy in 1994 and in 1997 was appointed Head of the International FMD Vaccine Bank. Currently leads a research group engaged in studies relating to high potency emergency or novel FMD vaccines. Has advised OIE, FAO and the European Union and sat on various working groups examining proposals and guidelines on foot-and-mouth disease vaccine testing, and has regularly contributed to the OIE manual of standards for diagnostic tests and vaccines since 1996.

Dr. Tony Garland

BVMS, PhD, MRCVS
CA and FMD project consultant.
Veterinarian, virologist and company director. Forty years experience with OIE List A virus diseases, particularly foot-and-mouth disease in all continents apart from Australasia. Eighteen years at the UK Institute for Animal Health, Pirbright Laboratory (a Reference Laboratory for a number of List A diseases). Eighteen years with the Wellcome Foundation, retiring as Director of Biological Production for medical and veterinary vaccines and biologicals. Six years as an independent consultant to the EU, UN-FAO, UK government, EUFMD and private companies.

Dr. Paul-Michael Agapow

BSc GradDipAdvCSci PhD
Informatician
Computational biologist, having worked and taught in Australia, US, UK and South Africa. Responsible for the ReLaIS epi-informatics project, including that in front of you.

Ms. Mary Marshall

Animal Health Resources (AHR) Director
Mary Marshall has a degree in psycholinguistics, and has worked for the UK's Medical Research Council studying neurology and language disorders. She then became involved in environment and agriculture, in the field of sustainable tropical forestry, at the University of Oxford and for the CGIAR in the establishment of a new International Agricultural Research Center in Indonesia. As a small-scale livestock keeper during the UK 2001 FMD epidemic, she became active in compiling scientific information for best control measures, and has established communication with an international network of leading FMD experts. She is a member of DEFRA FMD stakeholders group and their Veterinary Surveillance Strategy Business Assurance Group; the Foreign and Emerging Diseases Committee of the United States Animal Health Association; the American Association of Veterinary Laboratory Diagnosticians; and is a ProMED-mail Rapporteur.